Just my thoughts; LymPro will get us to .75 to1.00 PPS that will trigger a 4 for 1 R/S and then an uplist then after we partner on MANF for Rentinitis Pigmentosa with big Pharma, we will divide into two companies. I think we uplist by the end of this year and divide near the end of next year. JMO
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links